Home › Osteosarcoma › Ohio › Cincinnati
Osteosarcoma clinical trials in Cincinnati, OH
6 studies for Osteosarcoma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- St. Louis, MO10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Chicago, IL7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Los Angeles, CA7 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Aurora, CO6 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer19 studies
- Ovarian Cancer19 studies
- Obesity19 studies
- Prostate Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.